Bumrungrad Hospital Public Company Limited (BUGDF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Bumrungrad Hospital Public Company Limited (BUGDF) trades at $4.75 with AI Score 46/100 (Grade C). Bumrungrad Hospital Public Company Limited (BUGDF) is a premier healthcare provider based in Thailand, specializing in a wide range of medical services. Market cap: $3.78B, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for BUGDF: BUGDF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BUGDF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BUGDF: the 1 perspectives are evenly split.
How is this calculated? →Bumrungrad Hospital Public Company Limited (BUGDF) Healthcare & Pipeline Overview
Bumrungrad Hospital Public Company Limited (BUGDF) is a leading healthcare provider in Southeast Asia, renowned for its advanced medical facilities and comprehensive services, catering to both local and international patients in the medical tourism sector.
What Is the Investment Thesis for BUGDF?
Bumrungrad Hospital Public Company Limited (BUGDF) presents a compelling investment thesis driven by its robust financial metrics, including a market capitalization of $3.78B, a profit margin of 30%, and a gross margin of 52%. The company's strong performance is underpinned by its established reputation in medical tourism, which is expected to grow as global healthcare needs increase. Key growth catalysts include the expansion of specialized services, increased international patient inflow, and the potential for new healthcare partnerships. However, investors may want to evaluate risks related to operating in the OTC market, including liquidity challenges and competitive pressures from regional healthcare providers. Monitoring these factors will be crucial for assessing the company's long-term growth potential.
Based on FMP financials and quantitative analysis
BUGDF Key Highlights
- Market capitalization of $3.78B, reflecting strong investor confidence.
- Profit margin of 30%, indicating efficient cost management and high-quality service delivery.
- Gross margin of 52%, surpassing industry averages and showcasing operational efficiency.
- Beta of 0.23, suggesting lower volatility compared to the broader market.
- Dividend yield of 6.18%, providing attractive returns to shareholders.
Who Are BUGDF's Competitors?
BUGDF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| RMYHY Ramsay Health Care Limited | $7.44 | +2.59% | $6.84B | — |
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| NWKHY Netcare Limited | $7.17 | +0.00% | $843.64M | 50 |
| AONC American Oncology Network, Inc. | $10.00 | +0.00% | $292.48M | 50 |
| DCGO DocGo Inc. | $0.59 | +5.81% | $58.07M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BUGDF's Key Strengths?
- Strong reputation in medical tourism and international patient care.
- Diverse range of specialized medical services.
- High profit margins and operational efficiency.
- Established infrastructure with advanced medical technology.
What Are BUGDF's Weaknesses?
- Operating on the OTC market may limit liquidity.
- Dependence on international patients for revenue.
- Potential challenges in scaling operations amidst regional competition.
What Could Drive BUGDF Stock Higher?
- Expansion of specialized services in oncology and cardiology to attract more international patients.
- Strong patient inflow from medical tourism, bolstered by Bumrungrad's reputation.
- Continuous investment in advanced medical technologies to enhance service delivery.
- Strategic partnerships with international healthcare providers to broaden service offerings.
- Development of training programs for healthcare professionals to maintain high standards of care.
What Are the Key Risks for BUGDF?
- Increased competition from regional healthcare providers may impact market share.
- Regulatory changes in the healthcare sector could affect operations and profitability.
- Economic downturns may reduce the number of international patients seeking care.
- Operating on the OTC market presents liquidity risks for investors.
What Are the Growth Opportunities for BUGDF?
- Expansion of Specialized Services: Bumrungrad Hospital has the potential to expand its specialized services, particularly in high-demand areas such as oncology and cardiology. The global oncology market is projected to reach $200 billion by 2026, driven by rising cancer incidences. By enhancing its capabilities in these areas, Bumrungrad can attract more international patients seeking advanced treatments.
- Medical Tourism Growth: The medical tourism sector is expected to grow significantly, with an estimated market size of $100 billion by 2027. Bumrungrad's established reputation and accreditation can help capture a larger share of this market, particularly from patients in neighboring countries looking for quality healthcare services at competitive prices.
- Technological Advancements: The integration of advanced medical technologies and telemedicine services can enhance patient care and operational efficiency. The global telemedicine market is projected to grow at a CAGR of 23.5% from 2021 to 2028, providing Bumrungrad with opportunities to expand its service offerings and reach more patients.
- Partnerships and Collaborations: Strategic partnerships with international healthcare providers can enhance Bumrungrad's service offerings and patient referral networks. Collaborations can lead to increased patient inflow and shared resources, further strengthening its market position.
- Real Estate and Facility Management: Bumrungrad's management of real estate holdings presents an opportunity for revenue diversification. As healthcare facilities expand, the potential for leasing space to complementary healthcare services can generate additional income streams.
What Opportunities Does BUGDF Have?
- Growing demand for specialized medical services.
- Expansion of medical tourism market.
- Technological advancements in healthcare delivery.
- Strategic partnerships to enhance service offerings.
What Threats Does BUGDF Face?
- Increasing competition from regional healthcare providers.
- Changing healthcare regulations impacting operations.
- Economic fluctuations affecting patient inflow.
- Potential risks related to operating on the OTC market.
What Are BUGDF's Competitive Advantages?
- Established brand recognition in the Southeast Asian healthcare market.
- Accredited by international healthcare organizations, enhancing trust and credibility.
- Comprehensive range of specialized medical services under one roof.
- Strong focus on patient care and satisfaction, leading to high retention rates.
- Strategic location in Bangkok, attracting both local and international patients.
What Does BUGDF Do?
Bumrungrad Hospital Public Company Limited (BUGDF) was founded in 1980 in Bangkok, Thailand, and has since evolved into one of the region's foremost healthcare providers. The hospital operates a multi-specialty medical center that is equipped with advanced diagnostic, therapeutic, and intensive care capabilities. With a commitment to high-quality patient care, Bumrungrad offers a broad spectrum of services through approximately 56 specialized outpatient clinics and centers. These clinics cover diverse medical disciplines, including allergy, cardiology, oncology, dental care, and many others. The hospital is particularly well-known for its capacity to serve international patients, making it a significant player in the medical tourism industry. In addition to direct patient care, Bumrungrad engages in various related activities such as managing real estate holdings, conducting clinical research, and distributing pharmaceutical and medical goods. The company also operates a training and development center for healthcare professionals and provides patient referral services. With a substantial infrastructure that includes 580 hospital beds, Bumrungrad Hospital is strategically positioned to meet the growing healthcare demands both domestically and from international patients seeking quality medical services.
What Products and Services Does BUGDF Offer?
- Operate a multi-specialty hospital in Bangkok, Thailand.
- Provide a wide range of medical services, including outpatient clinics and specialized care.
- Engage in medical tourism, attracting international patients seeking quality healthcare.
- Conduct clinical research and distribute pharmaceutical and medical goods.
- Manage real estate holdings and operate a training center for healthcare professionals.
How Does BUGDF Make Money?
- Generate revenue through patient services, including inpatient and outpatient care.
- Earn income from specialized medical clinics and facilities.
- Engage in medical tourism, attracting international patients for treatment.
- Conduct clinical research and distribute medical products.
- Leverage real estate holdings for additional revenue streams.
What Industry Does BUGDF Operate In?
The healthcare industry, particularly the medical care facilities sector, is witnessing significant growth driven by increasing global healthcare demands and an aging population. Bumrungrad Hospital operates in a competitive landscape, with key players like Ramsay Health Care Limited (RMYHY) vying for market share. The medical tourism segment is expanding rapidly, with patients seeking high-quality care at competitive prices in countries like Thailand. This trend positions Bumrungrad favorably as it caters to both local and international patients, leveraging its advanced facilities and specialized services.
Who Are BUGDF's Key Customers?
- Domestic patients seeking specialized medical services.
- International patients traveling for medical tourism.
- Healthcare professionals seeking training and development.
- Insurance companies and healthcare networks.
- Pharmaceutical and medical goods distributors.
Company Profile
Bumrungrad Hospital Public Company Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Bangkok, TH. The company is led by CEO Artirat Charukitpipat. BUGDF has traded publicly since 2010.
Bumrungrad Hospital Public Company Limited Financial Trajectory
Bumrungrad Hospital Public Company Limited (BUGDF) reported $6.21B in revenue for Q1 2026, a decline of 4.6% compared to the prior quarter. The company recorded net income of $1.79B, with diluted EPS of $2.07. Revenue has contracted over three consecutive quarters, which investors in this mid-cap Healthcare stock should monitor closely. Across the four most recent quarters, BUGDF averaged $2.18 in diluted EPS.
How Bumrungrad Hospital Public Company Limited Is Valued
Bumrungrad Hospital Public Company Limited carries a market capitalization of $3.78B, placing it in the mid-cap category. Relative to its peer group, BUGDF's quantitative score of 46/100 is below the peer average of 63/100.
ROE 25%Key Financial Metrics
Return on equity for Bumrungrad Hospital Public Company Limited stands at 25.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 19.6%, showing how much profit it generates from its asset base. BUGDF trades at a trailing price-to-earnings ratio of 18.49, below the Healthcare sector average of ~23x. Its free cash flow yield is 3.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.48 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.1%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
Bumrungrad Hospital Public Company Limited's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 15.24 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project Bumrungrad Hospital Public Company Limited revenue of about $25.68B for fiscal 2026, with EPS near $9.40. The estimate reflects 18 contributing analysts.
BUGDF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Strong reputation in medical tourism and international patient care.
- Diverse range of specialized medical services.
- High profit margins and operational efficiency.
- Established infrastructure with advanced medical technology.
Bear Case
- Operating on the OTC market may limit liquidity.
- Dependence on international patients for revenue.
- Potential challenges in scaling operations amidst regional competition.
- Potential: Increased competition from regional healthcare providers may impact market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $6.21B | $1.79B | $2.07 |
| Q4 2025 | $6.51B | $1.88B | $2.17 |
| Q3 2025 | $6.51B | $2.03B | $2.35 |
| Q2 2025 | $6.02B | $1.86B | $2.14 |
Based on FMP financials and quantitative analysis
BUGDF Latest News
No recent news available for BUGDF.
BUGDF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BUGDF.
Price Targets
Wall Street price target analysis for BUGDF.
BUGDF MoonshotScore
What does this score mean?
The MoonshotScore rates BUGDF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Artirat Charukitpipat
CEO
Artirat Charukitpipat has extensive experience in the healthcare sector, having held various leadership roles within Bumrungrad Hospital. With a focus on operational excellence and patient care, he has contributed to the hospital's growth and reputation as a leading healthcare provider in Thailand. His educational background includes degrees in medicine and healthcare management, equipping him with the skills necessary to lead a complex healthcare organization.
Track Record: Under Artirat's leadership, Bumrungrad has expanded its service offerings and strengthened its position in the medical tourism market. His strategic decisions have led to improved patient satisfaction and operational efficiency, contributing to the hospital's impressive financial performance.
BUGDF OTC Market Information
The OTC Other tier represents stocks that do not meet the listing requirements of major exchanges like NYSE or NASDAQ. These stocks may have lower trading volumes and less stringent reporting requirements, which can lead to increased volatility and risk for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity can lead to price volatility and difficulty in executing trades.
- Less stringent reporting requirements may result in less transparency.
- Potential for increased regulatory scrutiny as the company operates on the OTC market.
- Market perception of OTC stocks may lead to undervaluation.
- Review the company's financial statements and performance metrics.
- Assess the competitive landscape and market position.
- Monitor news and updates related to healthcare regulations.
- Evaluate the company's growth strategy and expansion plans.
- Consider the risks associated with investing in OTC stocks.
- Accreditation by international healthcare organizations.
- Established history and reputation in the healthcare sector.
- Positive patient reviews and satisfaction ratings.
- Transparent communication of financial performance and strategic goals.
Common Questions About BUGDF (Healthcare)
What does Bumrungrad Hospital Public Company Limited do?
Bumrungrad Hospital Public Company Limited operates a multi-specialty hospital in Bangkok, Thailand, providing a wide range of medical services, including specialized outpatient clinics and advanced diagnostic care. The hospital is renowned for its focus on medical tourism, catering to both local and international patients seeking high-quality healthcare services. With a commitment to patient care, Bumrungrad also engages in clinical research and the distribution of medical goods.
What do analysts say about BUGDF stock?
Analysts generally view Bumrungrad Hospital Public Company Limited as a strong player in the healthcare sector, emphasizing its robust financial performance and growth potential. Key metrics such as a profit margin of 30% and a gross margin of 52% highlight operational efficiency. Analysts note the company's ability to attract international patients as a significant growth driver, although they also caution about risks related to liquidity due to its OTC trading status.
What are the main risks for BUGDF?
Bumrungrad Hospital Public Company Limited faces several risks, including increased competition from regional healthcare providers, which could impact its market share. Additionally, regulatory changes in the healthcare sector may affect operations and profitability. Economic downturns pose a risk as they could reduce the number of international patients seeking care. Furthermore, operating on the OTC market presents liquidity risks, potentially affecting share price stability.
What are the key factors to evaluate for BUGDF?
Bumrungrad Hospital Public Company Limited (BUGDF) holds an AI score of 46/100 (low). P/E: 18.5x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does BUGDF data refresh on this page?
BUGDF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BUGDF's recent stock price performance?
Bumrungrad Hospital Public Company Limited (BUGDF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong reputation in medical tourism and international patient care. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BUGDF overvalued or undervalued right now?
Bumrungrad Hospital Public Company Limited (BUGDF) trades at 18.5x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying BUGDF?
Before investing in Bumrungrad Hospital Public Company Limited (BUGDF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and subject to change. Investors should conduct their own due diligence.